-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TSI-GSD-200 in Rift Valley Fever
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TSI-GSD-200 in Rift Valley Fever Drug Details: TSI-GSD 200 vaccine is under investigation for the...
-
Product Insights
![]()
Rift Basin Res Corp – Melbourne Medicinal Cannabis Manufacturing Facility – Victoria
Equip yourself with the essential tools needed to make informed and profitable decisions with our Rift Basin Res Corp - Melbourne Medicinal Cannabis Manufacturing Facility - Victoria report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
![]()
Harbour Energy PLC – Company Profile
Harbour Energy PLC (Harbour Energy) formerly known as Premier Oil Plc is an independent upstream oil and gas company. It explores, develops, and produces crude oil and natural gas. The company is one of the largest independent oil and gas company in UK. The company has interests in the North Sea, Southeast Asia, Falkland Islands and Latin America. It explores under-explored proven hydrocarbon basins. Premier Oil explores rift basins in the North Falkland Basin, Asia, and offshore Brazil. It has...
Add to Basket -
Product Insights
![]()
Suswa Substation – New – 500/400 kV
Suswa Substation - New - 500/400 kV is a 500/400kV substation located at Suswa, Great Rift Valley, Kenya. The substation is planned and is expected to be commissioned in 2024. The Suswa Substation - New - 500/400 kV will be operated by Kenya Electricity Transmission Co Ltd. Suswa Substation - New - 500/400 kV Project profile includes core details such as project name, technology, voltage, status, plant proponents (owners, system operator etc.), as well as key operational data including year...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – AMG-634
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AMG-634 Drug Details AMG-634Â is under development for the treatment of tuberculosis, erythema nodosum leprosum...
-
Product Insights
![]()
Lessos Substation – New – 400/220 kV – Phase I
Lessos Substation - New - 400/220 kV - Phase I is a 400/220kV substation located at Lessos, Rift Valley, Kenya. The substation is planned and is expected to be commissioned in 2025. The Lessos Substation - New - 400/220 kV - Phase I will be operated by Kenya Electricity Transmission Co Ltd. Lessos Substation - New - 400/220 kV - Phase I Project profile includes core details such as project name, technology, voltage, status, plant proponents (owners, system operator etc.),...
-
Product Insights
![]()
Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Rift Valley Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Rift Valley Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rift Valley Fever, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.